Stock events for Teladoc Health, Inc. (TDOC)
Teladoc Health's stock price has declined significantly, hitting new 12-month lows in early February 2026. Q3 2025 financial results showed a net loss and a decrease in BetterHelp users. The fiscal year 2025 outlook anticipated a negative impact on margins due to Uplift. A non-cash goodwill impairment charge was recorded for the full year ended December 31, 2024. Analysts have largely maintained a "Hold" rating on the stock. The broader digital health sector underwent a recalibration in February 2026, impacting Teladoc Health's shares.
Demand Seasonality affecting Teladoc Health, Inc.’s stock price
Demand for Teladoc Health's services exhibits some seasonality. There is a rising demand for mental health services via virtual modalities. The company anticipates cyclical seasonality related to infectious disease visits in the fourth quarter. Virtual care visits accelerate when health plans waive cost-sharing and public health officials encourage virtual care use.
Overview of Teladoc Health, Inc.’s business
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company offering a suite of virtual care services. It operates in the Healthcare sector, divided into two segments: Integrated Care, providing virtual medical services and enterprise telehealth solutions, and BetterHelp, a direct-to-consumer mental health platform. The company serves employers, health plans, hospitals, insurance companies, and individual members.
TDOC’s Geographic footprint
Teladoc Health has a significant global presence, operating in over 130 countries, including the U.K., Australia, Canada, Spain, Portugal, Hungary, China, Chile, Brazil, France, Germany, India, Netherlands, Poland, Romania, Singapore, and Malaysia.
TDOC Corporate Image Assessment
Teladoc Health's brand reputation has been impacted by financial performance challenges and a class action lawsuit filed on May 17, 2024, alleging misleading information about advertising spending and its impact on revenue, particularly concerning the BetterHelp segment. The company's stock performance has also contributed to negative market sentiment.
Ownership
Teladoc Health, Inc. is a publicly traded company with its ownership heavily weighted towards institutional investors, who hold a controlling interest. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and Renaissance Technologies Llc. Individual ownership accounts for a smaller percentage of the shares.
Ask Our Expert AI Analyst
Price Chart
$5.26